Episode 20: The Role of Complement in Kidney Diseases

https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/31/f7/3d/31f73de3-e13a-79d8-1556-ce5e9782f2db/mza_1882848660028699420.jpg/600x600bb.jpg

KDIGO Conversations in Nephrology

KDIGO Communications

28 episodes

2 days ago

KDIGO Conversations in Nephrology features global experts covering a wide range of topics for clinicians treating patients with kidney disease.

Medicine

Health & Fitness

RSS

All content for KDIGO Conversations in Nephrology is the property of KDIGO Communications and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

KDIGO Conversations in Nephrology features global experts covering a wide range of topics for clinicians treating patients with kidney disease.

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/17207138/17207138-1756897292900-ae4b8aba62df8.jpg

Episode 20: The Role of Complement in Kidney Diseases

KDIGO Conversations in Nephrology

19 minutes 45 seconds

2 months ago

Episode 20: The Role of Complement in Kidney Diseases

Why does it matter if a kidney disease is complement-driven or complement-associated?

Dr. Matthew Pickering (Imperial College London, United Kingdom) explains this critical distinction and why it changes how clinicians approach diagnosis and treatment. The discussion explores promising new therapies such as C3 and C5 inhibitors and how biomarkers are paving the way for precision medicine in nephrology.

This episode is part of a four-part KDIGO Conversations in Nephrology series on complement-mediated kidney diseases, hosted by Dr. Carla Nester (University of Iowa Stead Family Children’s Hospital, United States).

This series was supported by Apellis and Sobi.